Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-12-20 Purchase | 2021-12-21 4:05 pm | Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer | 2,000 | $4.48 | $8,960 | 9,000 (Direct) | View |
2021-08-17 Purchase | 2021-08-19 4:05 pm | Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer | 4,000 | $6.21 | $24,840 | 7,000 (Direct) | View |
2021-06-09 Purchase | 2021-06-10 5:25 pm | Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer | 3,000 | $8.01 | $24,030 | 3,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer | 517,454 | $0 | 517,454 (Direct) | View |
2023-05-01 Option Award | 2023-05-02 6:49 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer | 383,299 | $0 | 383,299 (Direct) | View |
2023-02-01 Option Award | 2023-02-02 5:56 pm | N/A 2033-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer | 453,600 | $0 | 453,600 (Direct) | View |
2022-02-01 Option Award | 2022-02-02 5:38 pm | N/A 2032-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer | 108,000 | $0 | 108,000 (Direct) | View |
2020-09-11 Option Award | 2020-09-15 8:12 pm | N/A 2020-09-11 | Novus Therapeutics Inc. | NVUS | Gros David-Alexandre C Chief Executive Officer | 18,278 | $0 | 18,278 (Direct) | View |